Recent Advances in Pancreatic Neoplasms

Pancreatic neoplasms include different pathological entities with variable biological behavior and different treatment modalities. Surgery and adjuvant therapy are the cornerstones of the therapeutic approach; however, even after radical resection, the majority of patients experience disease recurre...

Full description

Saved in:
Bibliographic Details
Sonstige:
Year of Publication:2022
Language:English
Physical Description:1 electronic resource (176 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 03493nam-a2200913z--4500
001 993545291604498
005 20231214133332.0
006 m o d
007 cr|mn|---annan
008 202205s2022 xx |||||o ||| 0|eng d
035 |a (CKB)5680000000037579 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/81183 
035 |a (EXLCZ)995680000000037579 
041 0 |a eng 
100 1 |a Sperti, Cosimo  |4 edt 
245 1 0 |a Recent Advances in Pancreatic Neoplasms 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2022 
300 |a 1 electronic resource (176 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a Pancreatic neoplasms include different pathological entities with variable biological behavior and different treatment modalities. Surgery and adjuvant therapy are the cornerstones of the therapeutic approach; however, even after radical resection, the majority of patients experience disease recurrence and the prognosis of pancreatic cancer remains dismal. A multimodal therapeutic approach, based on a combination of neoadjuvant therapy, chemotherapy, radiotherapy, immunotherapy and surgery, appears fundamental to improving the outcomes. This Special Issue of the Journal of Clinical Medicine, entitled “Recent Advances in Pancreatic Neoplasms”, focuses on possible new strategies to treat pancreatic neoplasms. 
546 |a English 
650 7 |a Medicine  |2 bicssc 
650 7 |a Oncology  |2 bicssc 
653 |a PIWI proteins 
653 |a PIWIL3 
653 |a PIWIL4 
653 |a pancreatic cancer 
653 |a EMT 
653 |a chemoresistance 
653 |a motility 
653 |a HNF4A 
653 |a survival 
653 |a pancreatic neuroendocrine neoplasm 
653 |a primary pancreatic carcinoid 
653 |a serotonin-secreting pancreatic tumour 
653 |a serotonin-producing pancreatic tumour 
653 |a neoadjuvant chemotherapy 
653 |a response 
653 |a carbohydrate antigen 19-9 
653 |a fluorodeoxyglucose 
653 |a pancreatectomy 
653 |a positron emission tomography 
653 |a prognosis 
653 |a standardized uptake value 
653 |a Pancreatic ductal adenocarcinoma 
653 |a microRNAs 
653 |a pancreatic fistula 
653 |a pancreatic neoplasm 
653 |a renal cell carcinoma 
653 |a pancreatic neoplasms 
653 |a PET-CT scan 
653 |a pancreatic ductal adenocarcinoma 
653 |a pancreatic cancer prognosis 
653 |a completion total pancreatectomy 
653 |a pooled analysis 
653 |a recurrent pancreatic cancer 
653 |a repeated pancreatectomy 
653 |a pancreas 
653 |a neuropathy 
653 |a taxanes 
653 |a biomarker 
653 |a C-reactive protein to albumin ratio 
653 |a inflammation 
653 |a intraductal papillary mucinous neoplasm 
653 |a modified Glasgow prognostic score 
653 |a neutrophyl lymphocite ratio 
653 |a platelet-to-lymphocyte ratio 
653 |a robotic pancreatic surgery 
653 |a pancreato-gastrostomy 
653 |a low muscle mass 
653 |a sarcopenia 
653 |a pancreatic adenocarcinoma 
653 |a pancreatic surgery 
653 |a body composition 
776 |z 3-0365-3499-7 
776 |z 3-0365-3500-4 
700 1 |a Sperti, Cosimo  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 05:50:39 Europe/Vienna  |f system  |c marc21  |a 2022-05-14 21:41:54 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337850040004498&Force_direct=true  |Z 5337850040004498  |b Available  |8 5337850040004498